Jerome Stevens Pharmaceuticals, Inc.
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- United States
- Registered address
- 60 DaVinci Drive, Bohemia, New York (NY) 11716, United States (USA)
- Operations here
- analysislabelmanufacturepack
- FDA identifiers
- FEI 2431950 · DUNS 021130638
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- NAIBioresearch Monitoring2024-08-01
- VAIDrug Quality Assurance2022-06-15
- VAIBioresearch Monitoring2019-04-11
- VAIDrug Quality Assurance2017-03-30
- VAIDrug Quality Assurance2015-07-23
- VAIDrug Quality Assurance2013-11-21
- VAIDrug Quality Assurance2013-04-04
- NAIBioresearch Monitoring2012-03-27
- VAIDrug Quality Assurance2011-11-22
- VAIDrug Quality Assurance2010-11-23
- VAIDrug Quality Assurance2010-03-10
- VAIDrug Quality Assurance2009-05-06
Drugs this plant is listed as making
2 distinct drugs across 9 products name this site in their FDA label.
- BUTALBITAL, ASPIRIN, CAFFEINE and CODEINE PHOSPHATEAmneal Pharmaceuticals of New York, LLC
- ThyroidOliva Therapeutics, LLC
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.